Sven Wombwell
Article by: Sven Wombwell
Estimated 7 minutes read

There is much discussion about whether testosterone replacement therapy increases the risk of blood clots. Patients often ask whether testosterone thickens blood or raises the risk of a blood clot or stroke. This myth arises from confusion between a physiological state called erythrocytosis and a genetic disease called polycythemia vera. With testosterone therapy, red blood cell levels may increase, sometimes above what is considered normal.

However, no evidence exists that testosterone therapy elevates the risk of blood clots (venous thromboembolism) in those without an underlying condition, and no studies prove otherwise.

A new study of more than 30,000 commercially insured men is the first large comparative analysis to show no link between testosterone therapy and a higher risk of a blood clot. The study found that middle-aged and older men undergoing testosterone replacement therapy are not at increased risk of blood clots or deep vein thrombosis (DVT) (Baillargeon et al., 2015).

In fact, the American Urological Association (AUA) has made the following guideline statement regarding testosterone therapy to treat low testosterone and the risk of blood clots:

Guideline Statement 19: "Patients should be informed that there is no definitive evidence linking testosterone therapy to a higher incidence of VTE" (AUA, 2018).

" It is reassuring that as far as we can determine, no testosterone associated thromboembolic events have been reported to date.".

Supporting this, Holmegard et al. (2014) found that high endogenous concentrations of estradiol and testosterone in women and men are not associated with increased risk of venous thromboembolism (VTE), deep venous thrombosis (DVT), or pulmonary embolism (PE). Similarly, Svartberg et al. (2009) reported that higher levels of testosterone were not related to VTE risk and found no direct evidence that physiological testosterone levels or treatment doses are thrombogenic.

There is a Huge Difference in Thrombosis Risk Between TRT and Steroid Abuse!

Sometimes, the advice for men on a steroid cycle is mistakenly applied to those on TRT, especially in online forums or gyms. Men who take anabolic steroids in large doses (usually bodybuilders) have a high red cell count and worry about an increased risk of blood clots. They are often advised to give blood to lower blood counts and reduce the chance of a clot; this is called therapeutic phlebotomy. However, this practice does not apply to men on testosterone replacement therapy (TRT) to maintain optimal levels.

When treating testosterone deficiency using TRT, there is no increased risk of developing a blood clot unless there is an underlying condition. You essentially run the same risk of thrombosis as someone traveling by airplane or climbing a mountain.

Per Gonzales et al., their study indicates that testosterone affects a red blood cell precursor cell in the bone marrow, increasing red blood cell production. Interestingly, the study also shows that at high altitudes, testosterone levels slightly increase, causing the same process to help the body compensate for low oxygen (Gonzales, 2013).

"Testosterone stimulates erythropoiesis through the production of hematopoietic growth factors and acts directly on bone marrow, specifically the polychromatophilic erythroblast." "Serum testosterone levels are increased after acute exposure to high altitude. Therefore, testosterone may play a role in high-altitude tolerance" (Gonzales, 2013).

So Why Are We Not Concerned About People in Higher Altitudes Forming Clots?

  1. They are not at an increased risk for clots unless they already have a clotting disorder (thrombophilia).
  2. If doctors made these people give blood (Like with steroid abusers) because of "thickened blood," they would be guilty of malpractice. This comparison may sound extreme, but in this case, it could potentially kill that patient by decreasing their oxygen-carrying capacity, which you need to acclimate to higher altitudes.

Smoking and Red Blood Cell Volume

Chronic smokers are also people who typically have a high red blood cell volume. The main reason for this is that smoking decreases oxygenation due to lung damage. If we made those people give blood due to fears of them having a clot, doctors would be committing malpractice. By the way, chronic smokers are at increased risk of clots simply by being smokers. Can testosterone cause blood clots in smokers? No, it's smoking that's the issue.

Can Testosterone Cause Blood Clots in Cancer Patients?

Another study looked at the effects of exogenous testosterone on cancer patients. Interestingly, not one patient developed a blood clot while on testosterone therapy to treat low testosterone. Why is this noteworthy? People with cancer are more likely to form clots because cancer is a hypercoagulable state (meaning their blood clots more easily).

Despite cancer patients being at a higher risk for clots, testosterone therapy did not increase this risk. So, can testosterone cause blood clots in people with cancer? The studies say no (Nehra et al., 2012).

As a result, treating low testosterone with TRT is highly unlikely to cause a blood clot. If a clot does develop, it is likely unrelated to the prescribed testosterone therapy and more related to factors such as:

  • Heart conditions
  • Smoking
  • High blood pressure
  • High cholesterol
  • Diabetes

Why Young Men Don't Get Blood Clots from High Testosterone Levels

One of the most compelling facts supporting the safety of testosterone replacement therapy (TRT) is this: If TRT helps men achieve testosterone levels similar to their prime years, why did they not suffer from blood clots when they were younger? During their youth, men naturally produce higher levels of testosterone, similar to those achieved through TRT.

If high testosterone levels inherently increased the risk of blood clots, we would expect to see a higher incidence of blood clots among young men in their prime years. However, this is not the case. Younger men do not experience a higher risk of blood clots due to their naturally high testosterone levels. This observation strongly supports the idea that physiological levels of testosterone, whether natural or supplemented, do not elevate the risk of blood clots.

So, Can Testosterone Cause Blood Clots?

Many studies dispel the myths about exogenous testosterone increasing the risk of blood clots. One comprehensive study examined 71,407 men on testosterone therapy and found no increase in the likelihood of blood clots. They state:

"This study did not detect a significant association between testosterone replacement therapy and risk of DVT/PE in adult men with low sTT (serum total testosterone levels) who were at low to moderate baseline risk of DVT/PE" (Baillargeon et al., 2015).

Further studies have confirmed these findings. For instance, Kavoussi et al. (2019) found that medical treatments for hypogonadism do not significantly increase the risk of deep vein thrombosis over the general population risk. Additionally, Sharma et al. (2016) reported no association between testosterone replacement therapy and the incidence of DVT and pulmonary embolism in their retrospective cohort study of the Veterans Administration database.

By now, you can see that plenty of evidence backs up the claim that TRT, for the treatment of low testosterone, will not cause blood clots. In fact, it may decrease the likelihood of major adverse cardiovascular events, including heart attacks. Low testosterone causes decreased muscle mass in men, often accompanied by an increase in visceral and subcutaneous fat. This can lead to high blood pressure, high cholesterol, obesity, and diabetes, all of which can cause blood clots.

Editor's Note: This post was originally published on January 13, 2021, and has been completely updated to include the latest studies and ensure accuracy and comprehensiveness.

Heart hands

Check your levels today

From more lean muscle to increased energy, see if optimizing your hormones could be the key.

Share
References
1. Baillargeon J, Urban RJ, Morgentaler A, et al. Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy. Mayo Clinic Proceedings. 2015;90(8):1038-1045.
2. American Urological Association (AUA). Evaluation and Management of Testosterone Deficiency: AUA Guideline. 2018.
3. Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. The New England Journal of Medicine. 2004;350(5):482-492.
4. Gonzales GF. Serum testosterone levels and excessive erythrocytosis during the process of adaptation to high altitudes. Asian Journal of Andrology. 2013;15(3):368-374.
5. Holmegard HN, Nordestgaard BG, Schnohr P, Tybjaerg-Hansen A, Benn M. Endogenous sex hormones and risk of venous thromboembolism in women and men. Journal of Thrombosis and Haemostasis. 2014;12(3):297-305.
6. Svartberg J, Braekkan SK, Laughlin GA, Hansen JB. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study. European Journal of Endocrinology. 2009;160(5):833-838.
7. Kavoussi PK, Machen GL, Wenzel JL, et al. Medical Treatments for Hypogonadism do not Significantly Increase the Risk of Deep Vein Thrombosis Over General Population Risk. Urology. 2019;124:127-130. doi:10.1016/j.urology.2018.11.009
8. Sharma R, Oni OA, Chen G, et al. Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism: A Retrospective Cohort Study of the Veterans Administration Database. Chest. 2016;150(3):563-571. doi:10.1016/j.chest.2016.05.007
9. Nehra A, Agarwal N, et al. Exogenous testosterone and the risk of venous thromboembolism (VTE). European Urology. 2012;62(6):920-924.
See More